Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.

MLA

McHugh, Donal, et al. “Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.” Cell Host & Microbe, vol. 22, no. 1, July 2017, p. 61–73.e7. EBSCOhost, https://doi.org/10.1016/j.chom.2017.06.009.

APA

McHugh, D., Caduff, N., Barros, M. H. M., Rämer, P. C., Raykova, A., Murer, A., Landtwing, V., Quast, I., Styles, C. T., Spohn, M., Fowotade, A., Delecluse, H.-J., Papoudou-Bai, A., Lee, Y.-M., Kim, J.-M., Middeldorp, J., Schulz, T. F., Cesarman, E., Zbinden, A., & Capaul, R. (2017). Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression. Cell Host & Microbe, 22(1), 61–73.e7. https://doi.org/10.1016/j.chom.2017.06.009

Chicago

McHugh, Donal, Nicole Caduff, Mario Henrique M. Barros, Patrick C. Rämer, Ana Raykova, Anita Murer, Vanessa Landtwing, et al. 2017. “Persistent KSHV Infection Increases EBV-Associated Tumor Formation In Vivo via Enhanced EBV Lytic Gene Expression.” Cell Host & Microbe 22 (1): 61–73.e7. doi:10.1016/j.chom.2017.06.009.